Order Article Reprints

van de Wetering R, Ewald A, Welsh S, Kornberger L, Williamson SE, McElroy BD, Butelman ER, Prisinzano TE, Kivell BM. The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors. Molecules. 2023; 28(12):4848. https://doi.org/10.3390/molecules28124848

van de Wetering, Ross, Amy Ewald, Susan Welsh, Lindsay Kornberger, Samuel E. Williamson, Bryan D. McElroy, Eduardo R. Butelman, Thomas E. Prisinzano, and Bronwyn M. Kivell. 2023. "The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors" Molecules 28, no. 12: 4848. https://doi.org/10.3390/molecules28124848

van de Wetering, R., Ewald, A., Welsh, S., Kornberger, L., Williamson, S. E., McElroy, B. D., Butelman, E. R., Prisinzano, T. E., & Kivell, B. M. (2023). The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors. Molecules, 28(12), 4848. https://doi.org/10.3390/molecules28124848